Studies have found that BC patients with high expression of ALDHs or CD44+ cell sets have higher tolerance to chemotherapy, because these cells have the characteristics of BCSCs and are resistant to conventional chemotherapy [18]. This evidence concerns the gene CD44 and breast cancer.